FDA warns Skin Beauty Solutions that its chemical peel products are unapproved new drugs sold with acne and scar treatment claims.
What happened
FDA reviewed the company website in April 2024 and found it offered numerous chemical peel products, including multiple strengths of lactic acid, glycolic acid, combination glycolic and lactic acid, and salicylic acid. The website claims these products clear acne and scars, remove blackheads, remove dead skin cells, and treat dermatitis. FDA says the products are unapproved new drugs and notes adverse event reports of skin injuries from potent chemical peels, including burns, wounds, pain, swelling, and scarring.
What FDA found
FDA says the chemical peels are drugs because the website claims they treat acne, scars, and dermatitis and affect the skin.
FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1)FDA says the products are new drugs because they are not generally recognized as safe and effective for the claimed uses.
FD&C Act section 201(p), 21 U.S.C. 321(p)FDA says the products are sold without an FDA-approved drug application.
FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d)
What FDA wants
FDA asks the company to notify it in writing within fifteen working days of receipt of the letter about specific steps taken to address the violations, including steps to prevent recurrence and copies of related documentation. If corrective actions cannot be completed in that time, the company must state the reason for delay and the time within which it will do so; if it believes the products are not in violation, it must include reasoning and supporting information.
Who should pay attention
- online sellers of cosmetic chemical peels
- brands marketing exfoliating acids with acne or dermatitis claims
- estheticians and consumers using high-strength chemical peels
This is a summary. Read the original letter on fda.gov.